NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-escalation, single-centre, open-label, non-randomised, phase 1 trial https://t.co/Cy9odHv5eF
— The Lancet (@TheLancet) May 22, 2020
Thread (1/3) pic.twitter.com/97mqMDoal8